SVR rates in patients infected with genotype 1 or 4 (90%; 36/40 patients) were slightly higher compared to patients infected with genotype 3 (85.7%; 30/35 patients), but again the difference did not reach statistical significance ( p > 0.05).
← all excerpts
Sofosbuvir/velpatasvir in treatment-experienced HCV-infected patients - short report.
1
0.0500
0.0500